Clinical Trials Browser

Completed × Injections × 30 days × Clear all

NCT05516914 2026-04-01

A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors

Phase 1/2 Completed

Neoplasms

NCT05848466 2026-03-30

Assessment of Safety, Tolerability and Pharmacokinetics With BAT8010 for Injection in Advanced Malignant Solid Tumors Patients

Phase 1 Completed

Other solid neoplasm

Advanced or Metastatic Solid Tumors

NCT04948463 2026-03-20

ELSA-FN

Phase 4 Completed

Classical hematology

Neoplasms, Febrile Neutropenia